Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 9 of 32, showing 5 Applications out of 157 total, starting on record 41, ending on 45

# Protocol No Study Title Investigator(s) & Site(s)

41.

ECCT/21/06/08   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted   Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Saleh Mansoor
Site(s) in Kenya
1. Aga Kahn University Nairobi (Nairobi City county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county)
6. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county)
7. Kenya Medical Research Institute (Nairobi City county)
8. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
9. Moi University Clinical Research Centre (Uasin Gishu county)
10. KEMRI CCR-Butere County Hospital Site (Kakamega county)
 
View

42.

ECCT/08/08/02  
    Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples   
Principal Investigator(s)
1. Edwin Onyango Were
Site(s) in Kenya
1. Eldoret Site (Uasin Gishu county)
2. Kisumu Site (Kisumu county)
3. Thika Site (Kiambu county)
4. Nairobi Site (Nairobi City county)
 
View

43.

ECCT/13/04/09   Short-course RPT/INH for latent TB in HIV-infected individuals
        Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Deborah C. Langat
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project Clinical Research Centre (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

44.

ECCT/15/08/01   Rifapentine During Intensive Phase TB Treatment
     Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized, open-label, controlled, phase 3 clinical trial   
Principal Investigator(s)
1. Elisha Ochieng Okeyo
Site(s) in Kenya
KEMRICDC, KISUMU, KENYA
 
View

45.

ECCT/20/09/02   BEe-HIVe
     B-ENHANCEMENT OF HBV VACCINATIONIN PERSONS LIVING WITH HIV (BEe-HIVe) EVALUATION OF HEPLISAV-B,A5379   
Principal Investigator(s)
1. JOSPHAT KOSGEI
Site(s) in Kenya
KEMRI/KERICHO CLINIC RESEARCH CENTRE
 
View